Conditionally replicating viruses in cancer therapy-Reference-Cited by-同舟云学术

Conditionally replicating viruses in cancer therapy

Published:2003-04 Issue:8 Volume:10 Page:712-715
ISSN:0969-7128
Container-title:Gene Therapy
language:en
Short-container-title:Gene Ther

Author:

Connolly J B

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.nature.com/articles/3301898.pdf

Reference24 articles.

1. Alemany R, Balague C, Curiel DT . Replicative adenoviruses in cancer therapy. Nat Biotech 2000; 18: 723–727.

2. Kirn D . Replication-selective oncolytic adenoviruses: virotherapy aimed at genetic targets in cancer. Oncogene 2000; 19: 6660–6669.

3. Ganley I et al. A phase I study of Onyx-015, an E1B attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancer. Clin Cancer Res 2000; 6: 798–806.

4. Nemunaitis J et al. Selective replication an oncolysis in p53 mutant tumors with ONYX-015, and E1B-55kD gene-deleted adenovirus, in patients with advanced head and neck cancer: a phase II trial. Cancer Res 2000; 60: 6359–6366.

5. Papanastassoiu V et al. The potential for efficacy of the modified (ICP 34.5(-)) herpes simplex virus HSV1716 following intratumoural injection into human malignant glioma: a proof of priniciple study. Gene Ther 2002; 9: 398–406.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Conditionally replicative adenovirus as a therapy for malignant peripheral nerve sheath tumors;Molecular Therapy: Oncology;2024-06

2. Oncolytic viruses in immunotherapy;Cancer Immunology and Immunotherapy;2022

3. Biotechnological Implications;Environmental Biotechnology;2016

4. Adenovirus-based Immunotherapy for Prostate Cancer;Current Cancer Therapy Reviews;2012-11-01

5. Cancer immunotherapy: a paradigm shift for prostate cancer treatment;Nature Reviews Urology;2012-05-29